Brief: Veru Announces Preclinical Study Results That Demonstrate Sabizabulin Inhibits Poxviruses

Veru

11/04/2023 13:48

April 11 (Reuters) - Veru Inc  VERU.O :
    * VERU ANNOUNCES PRECLINICAL STUDY RESULTS THAT DEMONSTRATE
SABIZABULIN INHIBITS POXVIRUSES
    * VERU INC - SABIZABULIN INHIBITED CELL RELEASE AND
CELL-TO-CELL
SPREAD OF POXVIRUS IN A PRECLINICAL STUDY
    * VERU INC - VERU FURTHER EXPANDS STUDY OF SABIZABULIN FOR
TREATMENT OF POXVIRUS ACUTE RESPIRATORY DISTRESS SYNDROME
    * VERU INC - PLANS PRE-IND MEETING WITH FDA TO EVALUATE
SABIZABULIN UNDER ANIMAL RULE REGULATORY PATHWAY FOR TREATMENT
OF SMALLPOX VIRUS OUTBREAK

Source text for Eikon:  ID:nGNX4lcDvs 
Further company coverage:  VERU.O 

 ((Reuters.Briefs@thomsonreuters.com;))